SALT LAKE CITY, July 20, 2022--(BUSINESS WIRE)--Light Line Medical, Inc. today announced it has entered into a "know-how" License Agreement with Mayo Clinic to advance its visible light infection prevention system for off-the-shelf catheters. The collaboration will focus on the techn
Hi, what are you looking for?
Thoracic Drainage Devices Market: Key Findings
Transparency Market Research has published a new report on the global thoracic drainage devices market. According to the report, the global thoracic drainage devices market was valued at ~US$ 615 Mn in�
"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.
"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.
Imperative Care has announced that new data from studies evaluating the utility of its Zoom stroke solution were recently presented at the ongoing Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada).
Results from an independent, single-ce
Imperative Care has announced that new data from studies evaluating the utility of its Zoom stroke solution were recently presented at the ongoing Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada).
Results from an independent, single-ce
The U.S. Food and Drug Administration (FDA) has had a busy in July, approving Eko’s latest artificial intelligence (AI) algorithm for detecting heart murmurs and allowing Bayer to import a foreign-labeled contrast media agent.
Here is a review for some of the agency’s other big ca
No products in the cart.
1. At 58 months follow-up, fewer patients with Brugada Syndrome (BrS) and associated paroxysmal atrial fibrillation (AF) achieved freedom from atrial tachyarrhythmias, following pulmonary vein isolation (PVI) catheter ablation, compared to non-BrS patients with p
New York, United States – Key Companies Covered in the Central Venous Catheters (CVCs) Research are Intra Special Catheters GmbH, Smith Medical, Lepu Medical, ZOLL Medical Corporation, Vygon (UK) Ltd., Baihe Medical, Teleflex, TuoRen, AngioDynamics, B. Braun, Cook Medical, Citius Phar
"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.